Evaluate Cardiometabolic Risk in Youth
How well do waist-to-height ratios calculated using NHANES and WHO protocols indicate cardiometabolic risk in youth with diabetes?
Interesting Endo: T Trials & T1DM Self Care
Our March list includes Testosterone Trials results, self-management in patients transitioning to adult care, and cancer mortality risk with diabetes.
Dapagliflozin: All-Cause & Cardiovascular Mortality
Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?
Pump It Up: Steroid-Induced Diabetes
How would you treat glucose excursions in a patient treated with prednisone?
Make the Most of Online Physician Reviews
When choosing a healthcare provider, many consumers value online reviews of physicians. How can you make the most of this opportunity?
Interesting T2DM: Diabetic Retinopathy & Drug News
Our February list includes a newly approved drug combo, the ADA’s position statement on diabetic retinopathy, and lifestyle intervention studies.
Type 1 Diabetes: First-Ever Exercise Guidelines
A new set of guidelines will help people with type 1 diabetes mellitus exercise safely to avoid fluctuations in blood sugar.
Combo Therapy vs Insulin: Type 2 Diabetes
The Qatar Study investigated the efficacy of exenatide plus pioglitazone versus basal-bolus insulin in poorly-controlled type 2 diabetes.
Happiness in Endocrinology
I believe it is the human aspect of my job that keeps me from flinging my laptop against the wall every day.
Strength Training & Incident Diabetes, CVD Rates
Strength training can improve glycemic control among diabetics, but can it reduce rates of type 2 diabetes and cardiovascular disease?
By clicking Accept, you agree to become a member of the UBM Medica Community.